UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

A novel pre-clinical antibacterial pipeline database

PloS one, 2020-07, Vol.15 (7), p.e0236604-e0236604

2020

Volltextzugriff (PDF)

Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1420-1428

2015

Volltextzugriff (PDF)

The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.427-436

2015

Volltextzugriff (PDF)

Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed

Antimicrobial agents and chemotherapy, 2022-03, Vol.66 (3), p.e0199121-e0199121

2022

Volltextzugriff (PDF)

Innovation in Antimicrobial Resistance: The CARB-X Perspective

ACS infectious diseases, 2020-06, Vol.6 (6), p.1317-1322

2020

Volltextzugriff (PDF)

Narrow-Spectrum Antibacterial Agents-Benefits and Challenges

Antibiotics (Basel), 2020-07, Vol.9 (7), p.418

2020

Volltextzugriff (PDF)

Identification of Novel VEB β-Lactamase Enzymes and Their Impact on Avibactam Inhibition

Antimicrobial agents and chemotherapy, 2016-05, Vol.60 (5), p.3183-3186

2016

Volltextzugriff (PDF)

Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus

Antimicrobial agents and chemotherapy, 2015-09, Vol.59 (9), p.5278-5287

2015

Volltextzugriff (PDF)

Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs

Journal of antimicrobial chemotherapy, 2016-11, Vol.71 (11), p.3050-3057

2016

Volltextzugriff (PDF)

High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea

Antimicrobial agents and chemotherapy, 2014-09, Vol.58 (9), p.5585-5588

2014

Volltextzugriff (PDF)

Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC

Journal of antimicrobial chemotherapy, 2015-06, Vol.70 (6), p.1650-1658

2015

Volltextzugriff (PDF)

Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline

Journal of antimicrobial chemotherapy, 2016-01, Vol.71 (1), p.34-40

2016

Volltextzugriff (PDF)

Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations

Journal of antimicrobial chemotherapy, 2016-10, Vol.71 (10), p.2848-2855

2016

Volltextzugriff (PDF)

Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae

Antimicrobial agents and chemotherapy, 2015-03, Vol.59 (3), p.1478-1486

2015

Volltextzugriff (PDF)

Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48

ACS chemical biology, 2015-02, Vol.10 (2), p.591-600

2015

Volltextzugriff (PDF)

Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!"

Antimicrobial agents and chemotherapy, 2022-04, Vol.66 (4), p.e0022322-e0022322

2022

Volltextzugriff (PDF)

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model

Journal of antimicrobial chemotherapy, 2017-10, Vol.72 (10), p.2796-2803

2017

Volltextzugriff (PDF)

Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme

Journal of antimicrobial chemotherapy, 2014-11, Vol.69 (11), p.2942-2946

2014

Volltextzugriff (PDF)

In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.467-474

2015

Volltextzugriff (PDF)

Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline

Journal of antimicrobial chemotherapy, 2015-09, Vol.70 (9), p.2488-2498

2015

Volltextzugriff (PDF)

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pK a: Antibacterial Agents with an Improved Safety Profile

Journal of medicinal chemistry, 2012-08, Vol.55 (15), p.6916-6933

2012

Volltextzugriff (PDF)

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.343-347

2016

Volltextzugriff (PDF)

Ceftaroline Activity against mecC-Containing Staphylococcus aureus

Journal of clinical microbiology, 2015-09, Vol.53 (9), p.3102-3103

2015

Volltextzugriff (PDF)

A one health framework to estimate the cost of antimicrobial resistance

Antimicrobial resistance & infection control, 2020-11, Vol.9 (1), p.187-14, Article 187

2020

Volltextzugriff (PDF)

Exploitation of structural and regulatory diversity in glutamate racemases

Nature, 2007-06, Vol.447 (7146), p.817-822

2007

Volltextzugriff (PDF)

1 – 25 von 231

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(209)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(231)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(107)
Life Sciences & Biomedicine
(94)
Microbiology
(52)
Biological And Medical Sciences
(37)
Fundamental And Applied Biological Sciences. Psychology
(33)
Humans
(32)
Animals
(29)
Pharmacology & Pharmacy
(26)
Molecular Sequence Data
(25)
Anti-Bacterial Agents - Pharmacology
(23)
Bacterial Proteins - Genetics
(22)
Bacteriology
(22)
Amino Acid Sequence
(19)
Infectious Diseases
(19)
Microbial Sensitivity Tests
(19)
Base Sequence
(18)
Bacteria
(15)
Cloning, Molecular
(15)
Genetics
(15)
Pseudomonas Aeruginosa
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A novel pre-clinical antibacterial pipeline database

Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3

The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility

Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed

Innovation in Antimicrobial Resistance: The CARB-X Perspective

Narrow-Spectrum Antibacterial Agents-Benefits and Challenges

Identification of Novel VEB β-Lactamase Enzymes and Their Impact on Avibactam Inhibition

Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus

Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs

High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug-resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea

Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC

Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline

Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations

Characterization of the novel DNA gyrase inhibitor AZD0914: low resistance potential and lack of cross-resistance in Neisseria gonorrhoeae

Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48

Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!"

Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model

Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme

In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria

Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pK a: Antibacterial Agents with an Improved Safety Profile

In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program

Ceftaroline Activity against mecC-Containing Staphylococcus aureus

A one health framework to estimate the cost of antimicrobial resistance

Exploitation of structural and regulatory diversity in glutamate racemases

Aktive Filter

Suchergebnisse filtern